Of significance, the group that received HSC transfer alone, relative to the no treatment group, showed >2-fold decrease in expression of markers associated with tumor-derived immunosuppression (iNOS, IDO, and TGF-β) demonstrating a reprogramming of the global tumor microenvironment by HSC transfer (Fig. 1e). This evidence concerns the gene IDO1 and neoplasm.